Alexander Hillisch, VP, Head of Computational Molecular Design, Bayer AG |
11AM ET
12PM ET
FIRESIDE CHAT How AI and digital chemistry tools are enabling Recursion to accelerate and improve drug discovery and lead optimization |
Artificial Intelligence
Data
Drug Discovery
Discovery Informatics
Research and Development
Science & Technology
Headline Partner
Partner
Partner